EDAP to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026
EDAP (Nasdaq: EDAP) will release fourth quarter and full year 2025 financial results before market open on Wednesday, March 25, 2026.
Rhea-AI Summary
EDAP (Nasdaq: EDAP) will release fourth quarter and full year 2025 financial results before market open on Wednesday, March 25, 2026.
The company will host a conference call and webcast on March 25 at 8:30 a.m. EDT featuring CEO Ryan Rhodes, CFO Ken Mobeck, and Chief Accounting Officer François Dietsch. Dial-in and webcast registration details are provided.
Positive
- None.
Negative
- None.
Details
News Market Reaction – EDAP
On Mar 4, the day this news came out, EDAP closed 6.52% above the previous close.
Data tracked by StockTitan Argus for the Mar 4 session.
Key Figures
- Results period end
- December 31, 2025
- Fourth quarter and full year 2025 results period
- Earnings release date
- March 25, 2026
- Scheduled release of Q4 and full-year 2025 results
- Conference call time
- 8:30 a.m. EDT
- Time of earnings conference call and webcast
- Domestic dial-in
- 1-800-579-2543
- U.S. conference call dial-in number
- International dial-in
- 1-785-424-1789
- International conference call dial-in number
- Passcode
- EDAP
- Conference call passcode
Historical Context
-
Board refresh with new director appointment and one resignation.
-
Record Q4 and full-year 2025 HIFU revenue and 2026 guidance.
-
FDA 510(k) clearance for upgraded Focal One HIFU imaging and workflow.
-
Participation in Piper Sandler healthcare conference with investor meetings.
-
Q3 revenue growth, stronger HIFU segment, improved margin, narrower loss.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
EDAP to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026
Company to host conference call and webcast on Wednesday, March 25 at 8:30 a.m. EDT
AUSTIN, Texas, March 4, 2026 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2025, before market open on Wednesday, March 25, 2026.
An accompanying conference call and webcast will be conducted by Ryan Rhodes, Chief Executive Officer, Ken Mobeck, Chief Financial Officer, and François Dietsch, Chief Accounting Officer. Please refer to the information below for conference call dial-in information and webcast registration.
Call Details:
Date: Wednesday, March 25th
Time: 8:30 a.m. EDT
Domestic: 1-800-579-2543
International: 1-785-424-1789
Passcode: EDAP
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1751611&tp_key=27ba007fb5
About EDAP TMS SA
A recognized leader in robotic energy-based therapies, EDAP TMS develops, manufactures, promotes, and distributes worldwide minimally invasive medical devices for various conditions using ultrasound technology. By combining the latest technologies in imaging, robotics, and precise non-invasive energy delivery, EDAP introduced the Focal One® in Europe and the United States as a leading prostate focal therapy controlled by urologists, with the potential to expand to multiple indications beyond prostate cancer. For more information on the Company, please visit https://focalone.com.
Investor Contacts
Investor Relations
EDAP TMS SA
investor.relations@focalone.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.